GHK-Cu

Overview

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It is one of the more widely studied compounds in skin- and tissue-related research, recurring in regenerative, extracellular-matrix, and wound-related literature.

GHK-Cu is more visible than many niche research compounds, partly because of its presence in the cosmetic-science literature. Visibility and strength of evidence diverge here, however. The claims surrounding GHK-Cu vary considerably in scientific support, and that distinction shapes how this profile should be read.

The preclinical literature base is substantial, and the human-oriented discussion is broader than for many newer peptides. The evidence is stronger in some domains, wound-related models in particular, than in others. As with all compounds in the Peptalis database, this profile summarises the state of the research; it constitutes no efficacy claims or product recommendations.

Mechanism of action

GHK-Cu acts on signalling pathways associated with tissue remodelling and repair. Its copper-binding properties are regarded as central to its biological activity. Copper is a reactive metal; in bound form it can be directed toward controlled redox processes rather than indiscriminate oxidative damage. Through this route GHK-Cu influences extracellular-matrix dynamics and cellular response mechanisms.

Extracellular-matrix signalling

• Modulation of collagen synthesis and degradation pathways
• Influence on the expression of glycosaminoglycans and proteoglycans
• Interaction with decorin and other matrix-associated proteins

Tissue remodelling

• Stimulation of metalloproteinase activity in tissue-renewal contexts
• Recruitment of immune- and repair-associated cells in preclinical models
• Promotion of angiogenesis in wound-related experimental settings

Gene-expression modulation

• Reported influence on a broad range of genes related to tissue response and inflammation
• Upregulation of growth factors and antioxidant-associated genes in vitro
• The breadth of the gene-expression claims calls for methodological caution in interpretation

Research findings

• Stimulation of collagen synthesis in dermal-fibroblast models
• Influence on extracellular-matrix protein expression in vitro
• Improved wound contraction and closure in preclinical models
• Promotion of angiogenesis in experimental tissue-repair settings
• One small randomised human study (n=13) of topical GHK-Cu after CO₂ laser resurfacing found no significant objective difference in erythema or wrinkles, but did find higher patient-reported satisfaction
• Broad gene-expression modulation reported in transcriptomic analyses
• Modulation of inflammatory and anti-inflammatory signalling pathways

Skin and dermal models

• Stimulation of collagen synthesis in dermal-fibroblast models
• Influence on extracellular-matrix protein expression in vitro

Wound-related research

• Improved wound contraction and closure in preclinical models
• Promotion of angiogenesis in experimental tissue-repair settings

Human and gene-expression data

• One small randomised human study (n=13) of topical GHK-Cu after CO₂ laser resurfacing found no significant objective difference in erythema or wrinkles, but did find higher patient-reported satisfaction
• Broad gene-expression modulation reported in transcriptomic analyses
• Modulation of inflammatory and anti-inflammatory signalling pathways

Research context

GHK-Cu's preclinical literature base is more extensive than that of many niche peptides, partly because of its long-standing presence in cosmetic science and wound research. The strength of evidence differs sharply by endpoint, however. Wound-related preclinical models are relatively well established, while broader regenerative and anti-ageing claims are less consistently supported by controlled data. The controlled human data remain limited: one small randomised study with a mixed outcome.

This is also where the caution this compound requires comes from: its visibility in the cosmetic market can distort scientific interpretation. The scientific interest is genuine, but each specific claim must be weighed individually against the type and quality of the underlying data. That is precisely where the work lies: separating the well-supported wound biology from the broader claims is a natural next step for research groups in regenerative biology.

Open questions

GHK-Cu has stronger preclinical support than many niche peptides. For that very reason, each specific claim deserves individual assessment against the available evidence, rather than a blanket judgement on the compound as a whole.

• The controlled human data are limited to one small randomised study with a mixed outcome; larger studies with standardised endpoints are lacking
• The quality of evidence differs substantially by endpoint and by type of claim
• The formulation context (topical, injectable, concentration) strongly affects observed outcomes
• Broad claims about gene expression require tighter methodological control
• Commercial claims often exceed the strength of the published evidence, partly because of visibility in the cosmetic market

Research outlook

Controlled human studies with standardised endpoints within specific application domains

Systematic comparison of formulation types and delivery routes (topical versus injectable, concentration dependence)

Deeper characterisation of the gene-expression effects with tighter methodological controls

Separating the well-supported wound biology from the broader regenerative claims

Independent replication of the central cosmetic-science findings under controlled conditions

Scientific interest

Naturally occurring copper-binding tripeptide with one of the broader preclinical literature bases among research peptides.

Activity along multiple routes: extracellular-matrix remodelling, wound biology, and inflammatory signalling.

Intersection of cosmetic science and regenerative biology; this offers both entry points and a reason for interpretive caution.

The breadth of its gene-expression modulation makes GHK-Cu of interest for systems-biology approaches.

Specifications

References

1. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ · Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP · FEBS Letters · 1988
2. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ · Wegrowski Y, Maquart FX, Borel JP · Life Sciences · 1992
3. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin · Miller TR, Wagner JD, Baack BR, Eisbach KJ · Archives of Facial Plastic Surgery · 2006
4. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration · Pickart L, Vasquez-Soltero JM, Margolina A · BioMed Research International · 2015
5. GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis · Wang X, Liu B, Xu Q, Sun H, Shi M, Wang D, Guo M, Yu J, Zhao C, Feng B · Wound Repair and Regeneration · 2017
6. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data · Pickart L, Margolina A · International Journal of Molecular Sciences · 2018
7. The potential of GHK as an anti-aging peptide · Dou Y, Lee A, Zhu L, Morton J, Ladiges W · Aging Pathobiology and Therapeutics · 2020
8. Beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms · Mao S, Huang J, Li J, Sun F, Zhang Q, Cheng Q, Zeng W, Lei D, Wang S, Yao J · Frontiers in Pharmacology · 2025
9. Copper Complexes with New Glycyl-L-histidyl-L-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects · Greco V, Lanza V, Tomasello B, Naletova I, Cairns WRL, Sciuto S, Rizzarelli E · Bioconjugate Chemistry · 2025

Availability

In stock · Batch PEP-GHK-2026-01 · HPLC 99.23 % · released 21 Jun 2026

• GHK-Cu 50 mg · product page with price and batch CoA